Henry Du
Vermögen: - $ am 31.07.2026
Vermögen: - $ am 31.07.2026
Henry H.
Du is currently Director at Emmaus Life Sciences, Inc. since 2026 and Chief Financial Officer, VP-Finance & Accounting at Alpha Cognition, Inc. since 2024.
Formerly, Mr. Du was Senior Vice President-Accounting & Administration at Amplify Surgical, Inc. from 2022 to 2024 and VP-Finance & Senior Corporate Controller at Huyabio International LLC from 2021 to 2022.
Education includes undergraduate studies at Claremont McKenna College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALPHA COGNITION INC -.--% | 24.04.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPHA COGNITION INC. | Finanzdirektor/CFO | 21.10.2024 |
| EMMAUS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 16.04.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Amplify Surgical, Inc.
Amplify Surgical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets spinal implant devices | Verwaltungsdirektor | 01.10.2024 |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Finanzdirektor/CFO | 01.11.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Claremont McKenna College
Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amplify Surgical, Inc.
Amplify Surgical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets spinal implant devices | Health Technology |
Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen